Type
Internal restructuring
Country
France
Region
Location of affected unit(s)
Issy-les-Moulineaux (Hauts-de-Seine)
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.1 - Manufacture of basic pharmaceutical products

176 jobs
Number of planned job losses
Job loss
Announcement Date
16 September 2013
Employment effect (start)
14 January 2014
Foreseen end date
31 December 2014

Description

Pharmaceuticals company Janssen is to to cut about 176 of its 420 staff. This is mainly to affect sales and executive positions in the French headquarter at Issy-les-Moulineaux. 43 of the positions are already vacant.

The company lost the patent for one of its key products and faces a decline in sales.

The restructuring was initially announced to the works council on 16 September. Negotiations to conclude a social plan are to last until 14 January 2014.

The management has opened discussions with unions to create new activities that could lead to the creation of 34 positions, but the timeframe is unknown.

The company employs a total of 1,435 people in France. It is a subsidiary of the US group Johnson & Johnson.


Sources

  • 3 December 2013: L'usine Nouvelle
  • 5 December 2013: Le Quotidien du m├ędecin

Citation

Eurofound (2013), Janssen, Internal restructuring in France, factsheet number 76303, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/76303.